Clinical Trials Logo

Clinical Trial Summary

The purpose of this phase 1/2 clinical trial is to evaluate the efficacy and safety of allogeneic human umbilical cordstroma derived multipotent stem cells (hUCS-MSCs) in myocardial infarction (MI). All subjects will be taken into the bypass coronary surgery prior to the cell administration. This 2-year study comprise three independent groups, where the first group (n=20) will take no cells, second group will take autologous BM-MNCs (n=20), and third group (n=39) will be receiving allogeneic hUCS-MSCs. In all transplantations cells will be administered to the approximately 10 peri-infarct areas at one time. The infarct zone will be determined by the MR, SPECT and PET imaging. Only male subjects between 30-80 years of age. The efficiency of the therapy will be evaluated according to the parameters measured by MR, SPECT, and Echocardiography. All subject were taken into those measurements prior and 6, 12, 18 and 24 months after the operation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02323477
Study type Interventional
Source Ankara University
Contact
Status Terminated
Phase Phase 1/Phase 2
Start date February 2, 2015
Completion date December 30, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05139108 - TEE Monitoring and the Incidence of Postoperative Acute Kidney Injury in Coronary Artery Bypass Grafting
Completed NCT04523064 - POST-CABGDM: Empagliflozin in Perioperative CABG Phase 4
Not yet recruiting NCT05540249 - Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG N/A
Completed NCT01467232 - IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Phase 2
Completed NCT04631809 - Computed Tomography Coronary Angiography in Patients With a Previous Coronary Artery Bypass Graft Surgery Trial N/A
Completed NCT00073580 - Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) Phase 3
Terminated NCT03346278 - Text Message Intervention to Improve Cardiac Rehab Participation N/A
Completed NCT00303641 - Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients Phase 1
Completed NCT03823521 - Observational Study to Investigate the Effects of Training on the Administration of Cardioplexolâ„¢ Phase 3
Terminated NCT00789399 - A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis N/A
Completed NCT02592824 - Glutamate for Metabolic Intervention in Coronary Surgery II Phase 3
Not yet recruiting NCT05079724 - Acute Kidney Injury After Cardiac Surgery
Withdrawn NCT04379947 - Preoperative Use of Fractional Flow Reserve in CABG Use and Effectiveness of FFR-based CABG in Real-life Practice
Terminated NCT00858936 - Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery Phase 2
Recruiting NCT01386229 - A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery Phase 4
Completed NCT00653042 - Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA Phase 2
Completed NCT00318227 - Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients N/A
Completed NCT00372671 - Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation Phase 3
Completed NCT00209521 - Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery Phase 2
Not yet recruiting NCT05396690 - Safety and Efficacy of Remimazolam in OPCAB Surgery N/A